Purchase Order 36C26123P0702
Award Date 2/22/23
Potential Completion Date 5/22/23
Potential Value $48K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration awarded a $13,557 purchase order to Accredo Health Group, Inc. to deliver TYVASO in Palo Alto, California from January 18, 2023 through April 18, 2023. As a prime contractor supporting VA's Veterans Integrated Service Network 21, Accredo Health Group will provide the pulmonary arterial hypertension medication on a firm fixed price basis. No subcontractors or set aside designations were indicated. This purchase order was issued...
- Accredo Health Group, Inc. was awarded a firm fixed price purchase order without set aside designation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The order is for the delivery of UPTRAVI to locations in Palo Alto, California, with a potential value of $13,985.29 and an completion date of April 20, 2023. As a prime contractor, Accredo Health Group will utilize its specialty pharmacy services and distribution network to directly...
- The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical product UPTRAVI. The $125,284.68 contract supports the delivery of this medication directly to VA medical centers and facilities across the country, including in Palo Alto, California. This order, which does not have a set-aside designation, is part of Accredo Health...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the delivery of the specialty pharmaceutical Tyvaso. The total ceiling value of the contract is $81,342.18, with a period of performance through September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
- This is a $93,341.96 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the specialty pharmaceutical Tyvaso, which is used to treat pulmonary arterial hypertension. This contract is part of Accredo Health Group's ongoing work supporting the VA's Veterans Integrated Service Network (VISN) 21 with the distribution of specialty medications. The...
- Accredo Health Group, Inc. was awarded a $14,801.97 firm fixed price purchase order without a set-aside designation from the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 4. The contract is for the delivery of specialty pharmaceutical products to support VHA treatment programs for veterans located in Philadelphia, Pennsylvania. As the prime contractor, Accredo Health Group will distribute specialty medications directly to VA medical...
- This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the express delivery of second quarter pharmacy orders with a ceiling value of $86,938.57 and a completion date of July 24, 2017. Accredo Health Group, Inc. is a key distributor of complex and high-value medications, primarily serving the...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit specialty pharmacy company. The contract is for a 180-day supply of the medication Uptravi 600mcg, with a ceiling value of $78,557.34. The contract is not designated as a set-aside. Accredo Health Group, Inc. is a key distributor of complex and high-value medications to the VA's Veterans Integrated Service Networks (VISNs), with a focus on drugs...